Oncoscience AG   Report issue

For profit Phase 3
Founded: Wedel Germany (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2006
NCT00561691
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now